In depth analysis of the N-terminal bioactive domain of gastric inhibitory polypeptide
- 27 August 2004
- journal article
- Published by Elsevier in Life Sciences
- Vol. 75 (15) , 1857-1870
- https://doi.org/10.1016/j.lfs.2004.03.024
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetesBiochemical and Biophysical Research Communications, 2003
- Structure-Activity Relationships of Glucose-Dependent Insulinotropic Polypeptide (GIP)Biological Chemistry, 2003
- Zinc(II)-mediated enhancement of the agonist activity of histidine-substituted parathyroid hormone(1–14) analoguesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2001
- Family-B G-protein-coupled receptorsGenome Biology, 2001
- Miniglucagon (Glucagon 19–29), a Potent and Efficient Inhibitor of Secretagogue-induced Insulin Release through a Ca2+PathwayPublished by Elsevier ,1999
- Localization of the Domains Involved in Ligand Binding and Activation of the Glucose-Dependent Insulinotropic Polypeptide ReceptorEndocrinology, 1997
- chimeric peptides define the structural requirements for specific ligand-receptor interaction of GLP-1Regulatory Peptides, 1996
- Cell and Molecular Biology of the Incretin Hormones Glucagon-Like Peptide-I and Glucose-Dependent Insulin Releasing PolypeptideEndocrine Reviews, 1995
- Structure/Activity Characterization of Glucagon‐Like Peptide‐1European Journal of Biochemistry, 1994
- Glucagon-like peptide-1(7–36)amide: characterization of the domain responsible for binding to its receptor on rat insulinoma RINm5F cellsJournal of Molecular Endocrinology, 1990